Citadel Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Citadel Advisors’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,300	Closed	-$11K	–	14038
2020 Q4	$11K	Buy	+23,300	New	+$11.8K	﹤0.01%	10822
2015 Q3	–	Sell	-600	Closed	-$4K	–	9390
2015 Q2	$4K	Hold	600	–	–	﹤0.01%	8578
2015 Q1	$4K	Buy	+600	New	+$4.53K	﹤0.01%	8365

Other funds holding GEN

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Citadel Advisors's GEN Position: Q4 2020 in Review

Citadel Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 30,376 shares — an estimated $15.3K sold.

Citadel Advisors first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $1.18M in Q2 2015. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

Citadel Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 30,376 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $15.3K.
Citadel Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 18 quarters.
Citadel Advisors's Genesis Healthcare, Inc. position peaked at $1.18M in Q2 2015.
49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.